GENI

Value Q4, 24 TTM Total revenue — — Gross profit — — Operating expenses 66.1 M 258.4 M Selling/general/admin expenses — — Research & development — — Operating income -66.1 M -258.4 M Non-Operating Income, Total — — Interest expense, net of interest capitalized — — Non-Operating Income, excl. Interest Expenses — — Unusual income/expense — — Pretax income 66.26 M 939.15 M Equity in earnings — — Taxes — — Non-controlling/minority interest — — After tax other income/expense — — Net income before discontinued operations 66.26 M 939.15 M Discontinued operations — — Net income 66.26 M 939.15 M Dilution adjustment — — Preferred dividends — — Diluted net income available to common stockholders 66.26 M 939.15 M Basic earnings per share (Basic EPS) — — Diluted earnings per share (Diluted EPS) 0.31 — Average basic shares outstanding 211.01 M — Diluted shares outstanding 211.01 M — EBITDA — — EBIT — — Cost of revenue — — Other cost of goods sold — — Depreciation & amortization (cash flow) 66.1 M 258.4 M